ATE251309T1 - Verfahren zur bestimmung eines erhöhten sterblichkeitsrate - Google Patents

Verfahren zur bestimmung eines erhöhten sterblichkeitsrate

Info

Publication number
ATE251309T1
ATE251309T1 AT97922723T AT97922723T ATE251309T1 AT E251309 T1 ATE251309 T1 AT E251309T1 AT 97922723 T AT97922723 T AT 97922723T AT 97922723 T AT97922723 T AT 97922723T AT E251309 T1 ATE251309 T1 AT E251309T1
Authority
AT
Austria
Prior art keywords
determining
mortality rate
increased mortality
increased
mortality
Prior art date
Application number
AT97922723T
Other languages
English (en)
Inventor
Robert Long Island J Silverman
Original Assignee
Long Island Jewish Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Long Island Jewish Medical Ct filed Critical Long Island Jewish Medical Ct
Application granted granted Critical
Publication of ATE251309T1 publication Critical patent/ATE251309T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT97922723T 1996-05-31 1997-05-07 Verfahren zur bestimmung eines erhöhten sterblichkeitsrate ATE251309T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65658496A 1996-05-31 1996-05-31
PCT/US1997/007810 WO1997045734A1 (en) 1996-05-31 1997-05-07 Use of abp as a prognostic and diagnostic indicator

Publications (1)

Publication Number Publication Date
ATE251309T1 true ATE251309T1 (de) 2003-10-15

Family

ID=24633678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922723T ATE251309T1 (de) 1996-05-31 1997-05-07 Verfahren zur bestimmung eines erhöhten sterblichkeitsrate

Country Status (8)

Country Link
US (1) US6221611B1 (de)
EP (1) EP0935755B1 (de)
JP (1) JP3650939B2 (de)
AT (1) ATE251309T1 (de)
AU (1) AU734567B2 (de)
CA (1) CA2257220C (de)
DE (1) DE69725333T2 (de)
WO (1) WO1997045734A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5661457B2 (ja) * 2007-06-06 2015-01-28 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 腎疾患の予測診断

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens

Also Published As

Publication number Publication date
WO1997045734A1 (en) 1997-12-04
AU734567B2 (en) 2001-06-14
DE69725333D1 (de) 2003-11-06
CA2257220A1 (en) 1997-12-04
US6221611B1 (en) 2001-04-24
EP0935755A1 (de) 1999-08-18
EP0935755A4 (de) 2002-03-13
AU2832097A (en) 1998-01-05
HK1024299A1 (en) 2000-10-05
JP3650939B2 (ja) 2005-05-25
EP0935755B1 (de) 2003-10-01
CA2257220C (en) 2003-07-15
DE69725333T2 (de) 2004-12-30
JP2001521614A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
DE59809669D1 (de) Verfahren und messgerät zur bestimmung des blutdrucks
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
DE69736527D1 (de) Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
DE3667856D1 (de) Verfahren zur bestimmung der verteilung der dielektrizitaetskonstanten in einem untersuchungskoerper sowie messanordnung zur durchfuehrung des verfahrens.
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
DE69430231D1 (de) Biosensor zum Messen der Alkoholkonzentration, Verfahren zur Herstellung des Biosensors, und den Biosensor benutzendes Betrunkenheitsmessgerät
DE69114314D1 (de) Diagnostisches Verfahren zur Messung der Blutströmung.
DE68916998D1 (de) System zur Bestimmung der Leitungsimpedanz für Herzschrittmacher.
BR9607193B1 (pt) teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos.
DE68922874D1 (de) Verfahren und Gerät zur Blutdruckmessung.
DE69110098D1 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
DE69932191D1 (de) Vorrichtung zur Untersuchung von Körperflüssigkeit
ATE361024T1 (de) Vorrichtung und verfahren zur bestimmung des analytpegels
DE69735321D1 (de) Einrichtung zur Schätzung des Haftwertgradienten, Antiblockierregler und Verfahren zur Bestimmung des Regelbeginns
DE69130000D1 (de) Verfahren zur Messung, Analyse und Bestimmung der Bodenstruktur
NO984355D0 (no) FremgangsmÕte for mÕling av en analytts konsentrasjon
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE59004578D1 (de) Drucksensor und Verfahren zu seiner Herstellung.
ATE440283T1 (de) Sensor zur lumineszenz-optischen bestimmung eines analyten
SE9604815D0 (sv) A metod of diagnosis
DE69023577D1 (de) Ultraschallsystem zur Bestimmung des Profils von Festkörpern.
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
DE69333010D1 (de) Nicht-invasives verfahren und instrument zur messung des blutzuckerspiegels
DE59712563D1 (de) Vorrichtung zur Bestimmung der Blutsauerstoffsättigung
NO953770L (no) Analysemetode

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties